Informe de tamaño, participación y análisis de tendencias del mercado de pruebas de punto de atención (POCT) de GSA y Benelux: Resumen de la industria y pronóstico hasta 2032

Gsa And Benelux Point Care Testing Poct Market

Tamaño del mercado en miles de millones de dólares

Tasa de crecimiento anual compuesta (CAGR) : 12.10 %

USD 3.63 Billion USD 9.07 Billion 2024 2032

Período de pronóstico	2025 –2032
Tamaño del mercado (año base)	USD 3.63 Billion
Tamaño del mercado (año de pronóstico)	USD 9.07 Billion
Tasa de crecimiento anual compuesta (CAGR)	12.10 %
Jugadoras de los principales mercados	F. Hoffmann-La Roche Ltd Danaher Corporation Siemens Healthineers AG Bio-Rad Laboratories Inc. BIOMÉRIEUX

Mercado de pruebas en el punto de atención (POCT) de GSA y Benelux, por tipo de producto (productos para el control de glucosa, productos para el análisis de enfermedades infecciosas, productos para el control cardiometabólico, productos para el análisis de embarazo y fertilidad, productos para el análisis de hematología, productos para el control de la coagulación, productos para el análisis de drogas de abuso (DOA), productos para el análisis de orina, productos para el análisis de colesterol, productos para el análisis de marcadores tumorales/cancerosos, productos para el análisis de heces ocultas y otros), por plataforma (ensayos de flujo lateral/pruebas de inmunocromatografía, inmunoensayos, tiras reactivas, diagnóstico molecular, ensayos de química clínica, microfluídica, hematología, otros), por aplicación (glucosa en sangre, enfermedades infecciosas, monitorización de signos vitales, monitorización cardíaca, coagulación, hematología, monitorización no invasiva de SpO2, transfusión sanguínea, monitorización no invasiva de PCO2, sangre completa Análisis, otros), por modo de prescripción (pruebas con receta y pruebas sin receta, por usuario final (hospitales, atención domiciliaria, clínicas, laboratorios, centros de diagnóstico, laboratorios de patología, centros de cirugía ambulatoria, centros de atención para personas mayores, otros), por canal de distribución (licitación directa, ventas minoristas, ventas en línea y otros) - Tendencias y pronóstico de la industria hasta 2032

Tamaño del mercado de pruebas en el punto de atención (POCT)

El tamaño del mercado de pruebas en el punto de atención (POCT) de GSA se valoró en USD 3.63 mil millones en 2024 y se espera que alcance los USD 9.07 mil millones para 2032 , con una CAGR del 12,1% durante el período de pronóstico.
El tamaño del mercado de pruebas en el punto de atención (POCT) del Benelux se valoró en USD 882 millones en 2024 y se espera que alcance los USD 1.819 millones para 2032 , con una CAGR del 9,5 % durante el período de pronóstico.
Este crecimiento está impulsado por factores como la creciente demanda de resultados de diagnóstico rápidos, la creciente prevalencia de enfermedades crónicas e infecciosas y los avances en las tecnologías de diagnóstico portátiles.

Análisis del mercado de pruebas en el punto de atención (POCT)

Los dispositivos de pruebas en el punto de atención (POCT) desempeñan un papel fundamental en la obtención de resultados diagnósticos rápidos en el lugar de atención al paciente o cerca de él, lo que mejora significativamente la toma de decisiones clínicas en diversos entornos sanitarios. Estas pruebas se utilizan ampliamente en el manejo de enfermedades crónicas, enfermedades infecciosas y urgencias.
La demanda de soluciones POCT en las regiones GSA y Benelux está impulsada principalmente por la creciente carga de enfermedades crónicas, el crecimiento de la población de edad avanzada y un fuerte impulso hacia modelos de atención médica descentralizados y centrados en el paciente.
Se espera que Alemania domine el mercado de POCT con una participación del 28,04% en la región debido a su infraestructura de atención médica bien establecida, alto rendimiento de diagnóstico y adopción de tecnologías médicas avanzadas.
Se proyecta que los países del Benelux serán testigos de un fuerte crecimiento del mercado impulsado por iniciativas gubernamentales favorables, un aumento del gasto en atención médica y una creciente adopción de POCT tanto en entornos clínicos como de atención domiciliaria.
Se anticipa que el segmento de pruebas de glucosa en sangre, con una participación del 34,08%, liderará el mercado de POCT en la región, impulsado por la alta prevalencia de diabetes y la demanda de herramientas de monitoreo en tiempo real que empoderen a los pacientes en el manejo de la enfermedad.

Alcance del informe y segmentación del mercado de pruebas en el punto de atención (POCT)

Atributos	Microscopios oftálmicos operativos: perspectivas clave del mercado
Segmentos cubiertos	Por tipo de producto : Productos para el control de glucosa, productos para el análisis de enfermedades infecciosas, productos para el control cardiometabólico, productos para el análisis de embarazo y fertilidad, productos para el análisis hematológico, productos para el control de la coagulación, productos para el análisis de drogas de abuso (DOA), productos para el análisis de orina, productos para el análisis de colesterol, productos para el análisis de marcadores tumorales/cáncer, productos para el análisis de heces ocultas y otros. Por plataforma: Ensayos de flujo lateral/Pruebas de inmunocromatografía, Inmunoensayos, Tiras reactivas, Diagnóstico molecular, Ensayos de química clínica, Microfluídica, Hematología y otros Por aplicación: Glucosa en sangre, Enfermedades infecciosas, Monitoreo de signos vitales, Monitoreo cardíaco, Coagulación, Hematología, Monitoreo no invasivo de SpO2, Transfusión de sangre, Monitoreo no invasivo de PCO2, Análisis de sangre completa y otros. Por modo de prescripción: Pruebas OTC, Pruebas con prescripción Por usuario final: hospitales, atención domiciliaria, clínicas, laboratorios, centros de diagnóstico, laboratorios de patología, centros de cirugía ambulatoria, centros de atención a personas mayores y otros. Por canal de distribución : Licitación directa, Ventas minoristas, Ventas en línea y otros
Países cubiertos	GSA Alemania Suiza Austria BENELUX Bélgica Países Bajos Luxemburgo
Actores clave del mercado	F. Hoffmann-La Roche Ltd (Suiza) Corporación Danaher (EE. UU.) Siemens Healthineers AG (Alemania) Bio-Rad Laboratories, Inc. (EE. UU.) BIOMÉRIEUX (Francia) BD (EE. UU.) Corporación QuidelOrtho (EE. UU.) Hologic, Inc. (EE. UU.) Thermo Fisher Scientific Inc. (EE. UU.) Abbott (EE. UU.) Werfen (España) QIAGEN (Alemania) Corporación Sysmex (Japón) EKF Diagnostics Holdings plc. (Reino Unido) Sekisui Diagnostics (EE. UU.) Meridian Bioscience (EE. UU.) Binx Health, Inc. (EE. UU.) Trinity Biotech (Irlanda) Sienco, Inc. (EE. UU.) ACCUBIOTECH CO., LTD. (China)
Oportunidades de mercado	Aumento de la concienciación y la promoción de las pruebas en el punto de atención Iniciación estratégica y toma de decisiones por parte de los actores del mercado
Conjuntos de información de datos de valor añadido	Además de los conocimientos sobre escenarios de mercado como valor de mercado, tasa de crecimiento, segmentación, cobertura geográfica y actores principales, los informes de mercado seleccionados por Data Bridge Market Research también incluyen análisis de importación y exportación, descripción general de la capacidad de producción, análisis del consumo de producción, análisis de tendencias de precios, escenario de cambio climático, análisis de la cadena de suministro, análisis de la cadena de valor, descripción general de materias primas/consumibles, criterios de selección de proveedores, análisis PESTLE, análisis de Porter y marco regulatorio.

Tendencias del mercado de pruebas en el punto de atención (POCT)

Avances en diagnósticos rápidos y pruebas descentralizadas en GSA y Benelux

Una tendencia destacada que configura el mercado de POCT en las regiones GSA y Benelux es la creciente integración de la conectividad digital, sensores miniaturizados y capacidades de prueba multiplex en dispositivos de punto de atención.
Estas innovaciones mejoran la velocidad y la precisión del diagnóstico, lo que permite a los proveedores de atención médica tomar decisiones oportunas, especialmente en situaciones de emergencia, manejo de enfermedades crónicas y detección de enfermedades infecciosas.

Por ejemplo, los sistemas POCT equipados con transmisión inalámbrica de datos e integración de registros médicos electrónicos (EHR) se utilizan cada vez más en entornos de atención primaria en Alemania y los Países Bajos para agilizar el seguimiento de los pacientes y reducir las visitas al hospital.

Estos avances están revolucionando los diagnósticos descentralizados, apoyando modelos de atención basados en el valor y acelerando el cambio hacia una atención médica centrada en el paciente en las regiones de GSA y Benelux.
El creciente énfasis en la atención médica preventiva, combinado con un fuerte apoyo gubernamental para la detección temprana de enfermedades, continúa impulsando la demanda de soluciones POCT de última generación con un rendimiento analítico y una facilidad de uso mejorados.

Dinámica del mercado de pruebas en el punto de atención (POCT)

Conductor

Aumento del uso de pruebas de detección en centros de salud

El creciente uso de pruebas en el punto de atención (POC) en los centros de atención médica está revolucionando la forma en que los proveedores de atención médica diagnostican y tratan las enfermedades.
Ante la creciente necesidad de resultados diagnósticos rápidos y precisos, los profesionales sanitarios recurren a las pruebas en el punto de atención para mejorar la atención al paciente. Este cambio es especialmente evidente en urgencias, consultas externas y centros de diagnóstico, donde la rapidez en la toma de decisiones es crucial.
Las pruebas POC permiten a los proveedores de atención médica obtener resultados inmediatos en el punto de atención, lo que elimina la necesidad de que los pacientes esperen los resultados de laboratorio y reduce significativamente el tiempo de diagnóstico y tratamiento.
Además, las pruebas POC son altamente portátiles y fáciles de usar, lo que las hace ideales para su uso en diversos entornos de atención médica, desde clínicas rurales hasta grandes hospitales.
La creciente prevalencia de enfermedades crónicas y la creciente demanda de soluciones de atención médica eficientes impulsan aún más la adopción de pruebas POC, ya que permiten un mejor seguimiento de las enfermedades, especialmente en afecciones como diabetes, enfermedades cardiovasculares y enfermedades infecciosas.
A medida que los centros de atención médica incorporan cada vez más estas tecnologías en sus flujos de trabajo, la demanda de pruebas en el punto de atención continúa creciendo, actuando como un impulsor clave para la expansión del mercado.

Por ejemplo,

En marzo de 2024, según el NCBI, la rápida respuesta de las pruebas POCT mejora la toma de decisiones clínicas, reduce el tiempo de gestión y mejora la eficiencia del triaje, especialmente en los servicios de urgencias. Su flexibilidad se extiende a entornos prehospitalarios, hospitales de campaña y durante desastres, concentraciones masivas o zonas con alta aglomeración.
En noviembre de 2024, según el artículo publicado por OBJECTIVE Investment Banking & Valuation, la transición hacia las pruebas en el punto de atención (POCT) ha revolucionado la atención médica al llevar el diagnóstico directamente al centro de atención del paciente. Su velocidad, conveniencia y eficiencia las hacen invaluables en entornos de emergencia, ambulatorios y remotos. A medida que crece la demanda de diagnósticos rápidos.

La creciente adopción de las pruebas en el punto de atención (POC) en los centros de salud está transformando el diagnóstico y el manejo de enfermedades. Ante la necesidad de obtener resultados rápidos y precisos, los profesionales de la salud están utilizando las pruebas en el punto de atención para mejorar la atención al paciente.

Oportunidad

Aumento de la concienciación y la promoción de las pruebas en el punto de atención

A medida que los profesionales de la salud, los formuladores de políticas y el público en general se informan mejor sobre los beneficios de las pruebas POCT (como resultados rápidos, mejor gestión de los pacientes, tiempos de respuesta reducidos y el potencial de realizar pruebas descentralizadas), existe una creciente demanda de estas soluciones.
Los esfuerzos de defensa de los grupos de pacientes, las organizaciones profesionales y los organismos de la industria resaltan aún más el valor de la POCT en diversos entornos clínicos, incluidos los departamentos de emergencia, la atención primaria e incluso en entornos comunitarios.
Esta mayor comprensión y apoyo se traducen en una mayor voluntad de invertir e integrar POCT en los flujos de trabajo de atención médica existentes, expandiendo el tamaño y el alcance del mercado al impulsar una mayor adopción y utilización.

Por ejemplo,

En abril de 2023, el NCBI declaró que una abrumadora mayoría de los médicos generales alemanes (MG), un notable 93%, consideraban que las pruebas en el punto de atención (POCT) eran valiosas herramientas de diagnóstico en su práctica. Citaron principalmente la capacidad de tomar decisiones inmediatas sobre el manejo del paciente y la mayor certeza diagnóstica como las principales ventajas de utilizar las POCT.
Según un artículo titulado "Pruebas en el punto de atención en atención primaria en los Países Bajos", publicado por Open Repository, los profesionales sanitarios utilizan cada vez más las pruebas diagnósticas en el punto de atención (POC) para tomar decisiones terapéuticas. La principal ventaja de estas pruebas es su capacidad para ofrecer resultados rápidos directamente en el lugar del paciente o cerca de él.

Además, esta mayor concienciación y promoción puede generar cambios favorables en las políticas e iniciativas de financiación que apoyen la implementación más amplia de la POCT. Los gobiernos y los sistemas de salud de la GSA y el Benelux, reconociendo el potencial de la POCT para mejorar la eficiencia y el acceso a los diagnósticos, podrían asignar más recursos a la adopción de estas tecnologías.
La promoción también puede influir en los organismos reguladores para que agilicen los procesos de aprobación de dispositivos POCT innovadores, acelerando así su entrada al mercado. Esto crea un entorno más propicio para el crecimiento del mercado, animando tanto a los actores consolidados como a los nuevos participantes a invertir en el desarrollo e implementación de soluciones POCT avanzadas para satisfacer la creciente demanda.

Restricción/Desafío

Preocupaciones sobre la seguridad y privacidad de los datos

A medida que más dispositivos POCT se integran con plataformas digitales, la recopilación, transmisión y almacenamiento de información confidencial de los pacientes aumenta los riesgos de acceso no autorizado y filtración de datos. Los datos sanitarios, que incluyen información médica personal, requieren una protección rigurosa bajo leyes como la HIPAA y el RGPD, lo que genera complejidades adicionales de cumplimiento para fabricantes y proveedores de atención médica.
La falta de marcos de seguridad sólidos y protocolos de cifrado en algunos dispositivos POCT amplifica aún más estas preocupaciones.
Además, la reticencia de los pacientes a compartir sus datos médicos debido a los riesgos para la privacidad puede dificultar su adopción generalizada, especialmente en regiones donde la confianza en las soluciones de salud digital es limitada. El desarrollo continuo de sistemas seguros y que respeten la privacidad es crucial, pero las preocupaciones actuales actúan como un freno, ralentizando el ritmo de innovación y adopción en el mercado POCT de GSA y Benelux.

Por ejemplo,

En julio de 2021, según el blog publicado por MDPI, un aspecto relevante a considerar en relación con los riesgos de ciberseguridad y privacidad son los sistemas de punto de atención (POC) de atención médica, ampliamente utilizados en hospitales. Los POC son plataformas que integran dispositivos y aplicaciones para recopilar, procesar y visualizar datos. Al utilizar grandes cantidades de datos, que contienen información personal de salud y datos médicos sensibles, comunicados a través de diversos sistemas POC, plataformas analíticas de backend, estaciones de trabajo de usuarios y teléfonos inteligentes, se hace evidente la existencia de múltiples amenazas que causan fugas de datos o incidentes de violación que ponen en peligro la vida del paciente. Las pruebas en el punto de atención son vulnerables a las fugas de datos, lo que frena el crecimiento del mercado.

La seguridad y la privacidad de los datos son importantes retos para el mercado de pruebas en el punto de atención (POCT) de la GSA y el Benelux. A medida que más dispositivos se conectan a plataformas digitales, aumenta el riesgo de acceso no autorizado y de vulneraciones de datos, especialmente en lo que respecta a la información confidencial de los pacientes. El cumplimiento de normativas como la HIPAA y el RGPD añade complejidad a fabricantes y profesionales sanitarios. La falta de una seguridad sólida en algunos dispositivos y la preocupación de los pacientes por la privacidad pueden ralentizar la adopción, especialmente en regiones con poca confianza en las soluciones de salud digital. El desarrollo de sistemas seguros y que respeten la privacidad es esencial para superar estas barreras.

Alcance del mercado de las pruebas en el punto de atención (POCT)

El mercado está segmentado según la aplicación, el tipo de producto, la tecnología, el tipo de aumento, el usuario final y el canal de distribución.

Segmentación	Subsegmentación
Por tipo de producto	Productos para el control de la glucosa Productos para pruebas de enfermedades infecciosas Productos de monitorización cardiometabólica Productos para pruebas de embarazo y fertilidad Productos para pruebas hematológicas Productos para el control de la coagulación Productos para pruebas de drogas de abuso (DOA) Productos para pruebas de análisis de orina Productos para la prueba del colesterol Productos para pruebas de marcadores tumorales y de cáncer Productos para pruebas de heces ocultas Otros
Por plataforma	Ensayos de flujo lateral/Pruebas de inmunocromatografía Inmunoensayos Varillas de nivel Diagnóstico molecular Ensayos de química clínica Microfluídica Hematología Otros
Por aplicación	Glucosa en sangre Enfermedades infecciosas Monitoreo de signos vitales Monitoreo cardíaco Coagulación Hematología Monitoreo no invasivo de SpO2 Transfusión de sangre Monitoreo no invasivo de PCO2 Análisis de sangre completa Otros
Por modo de prescripción	Pruebas de venta libre Pruebas basadas en prescripción médica
Por el usuario final	Hospitales Clínicas de atención domiciliaria Laboratorios Centros de diagnóstico Laboratorios de patología Centros de cirugía ambulatoria Centros de atención para personas mayores Otros
Por canal de distribución	Licitación directa Ventas minoristas Ventas en línea Otros

Se proyecta que en 2025, los productos de monitoreo de glucosa dominarán el mercado con la mayor participación en el segmento de tipo de producto.

Se espera que el segmento de productos de monitoreo de glucosa domine el mercado de pruebas en el punto de atención (poct) con la mayor participación del 34,08 % en 2025 debido a la alta prevalencia de diabetes y la frecuente necesidad de pruebas de glucosa en sangre convenientes e inmediatas.

Se espera que los ensayos de flujo lateral/pruebas de inmunocromatografía representen la mayor participación durante el período de pronóstico en el segmento de plataforma.

En 2025, se espera que el segmento de ensayos de flujo lateral/pruebas de inmunocromatografía domine el mercado con la mayor participación de mercado del 37,28% debido a su simplicidad, resultados rápidos, rentabilidad e idoneidad para una amplia gama de aplicaciones de diagnóstico fuera de los entornos de laboratorio tradicionales.

Análisis regional del mercado de pruebas en el punto de atención (POCT)

Alemania posee la mayor participación en el mercado de pruebas en el punto de atención (POCT)

Alemania domina el mercado de pruebas en el punto de atención (POCT) con una participación del 82,06% , dentro de la región GSA, impulsada por una infraestructura de atención médica altamente desarrollada, una adopción generalizada de tecnologías de diagnóstico innovadoras y un fuerte énfasis en la medicina preventiva y personalizada.
El país tiene una participación significativa debido a la creciente demanda de soluciones de diagnóstico rápidas y precisas, especialmente en el manejo de enfermedades crónicas como diabetes, enfermedades cardiovasculares e infecciones respiratorias.
Los marcos de reembolso de apoyo, las iniciativas de salud digital respaldadas por el gobierno y la sólida inversión en I+D en atención médica impulsan aún más el crecimiento del mercado.
Además, la creciente implementación de POCT en departamentos de emergencia, entornos de atención primaria y atención médica domiciliaria, junto con un enfoque en la reducción de la carga hospitalaria, está impulsando la expansión del mercado en toda Alemania.

Se proyecta que Países Bajos registre la tasa de crecimiento anual compuesta (TCAC) más alta en el mercado de pruebas en el punto de atención (POCT)

Se espera que los Países Bajos sean testigos de un sólido crecimiento en el mercado de pruebas en el punto de atención (POCT) con una participación del 54,40% , impulsado por su fuerte enfoque en la atención médica digital, la detección temprana de enfermedades y los modelos de atención centrados en el paciente.
El envejecimiento de la población del país y la creciente prevalencia de enfermedades crónicas como diabetes, enfermedades cardiovasculares y trastornos respiratorios están impulsando la demanda de soluciones de diagnóstico rápidas y descentralizadas.
Con un sistema de atención primaria bien establecido y políticas sanitarias progresistas, los Países Bajos siguen siendo un país clave en la adopción de tecnologías POCT, en particular en entornos de salud comunitarios, clínicas de médicos generales y servicios de atención domiciliaria.
La creciente integración de los dispositivos POCT con los historiales clínicos electrónicos (HCE), el apoyo de las aseguradoras de salud a la innovación diagnóstica y la participación activa en iniciativas de tecnología sanitaria en toda la UE están fortaleciendo aún más las perspectivas del mercado.
Las colaboraciones entre instituciones académicas, empresas tecnológicas emergentes y empresas de diagnóstico están acelerando la innovación y el desarrollo local de soluciones POCT avanzadas y fáciles de usar adaptadas al sistema de salud holandés.

Cuota de mercado de las pruebas en el punto de atención (POCT)

El panorama competitivo del mercado ofrece detalles por competidor. Se incluye información general de la empresa, sus estados financieros, ingresos generados, potencial de mercado, inversión en investigación y desarrollo, nuevas iniciativas de mercado, presencia global, plantas de producción, capacidad de producción, fortalezas y debilidades de la empresa, lanzamiento de productos, alcance y variedad de productos, y dominio de las aplicaciones. Los datos anteriores se refieren únicamente al enfoque de mercado de las empresas.

Los principales líderes del mercado que operan en el mercado son:

F. Hoffmann-La Roche Ltd (Suiza)
Corporación Danaher (EE. UU.)
Siemens Healthineers AG (Alemania)
Bio-Rad Laboratories, Inc. (EE. UU.)
BIOMÉRIEUX (Francia)
BD (EE. UU.)
Corporación QuidelOrtho (EE. UU.)
Hologic, Inc. (EE. UU.)
Thermo Fisher Scientific Inc. (EE. UU.)
Abbott (EE. UU.)
Werfen (España)
QIAGEN (Alemania)
Corporación Sysmex (Japón)
EKF Diagnostics Holdings plc. (Reino Unido)
Sekisui Diagnostics (EE. UU.)
Meridian Bioscience (EE. UU.)
Binx Health, Inc. (EE. UU.)
Trinity Biotech (Irlanda)
Sienco, Inc. (EE. UU.)
ACCUBIOTECH CO., LTD. (China)

Últimos avances en el mercado de pruebas en el punto de atención (POCT) de GSA y Benelux

En diciembre de 2023, Roche adquirió partes seleccionadas de la innovadora tecnología de punto de atención de LumiraDx, lo que reforzó su portafolio de diagnóstico. Esta adquisición permite realizar pruebas más rápidas y asequibles en diversas enfermedades. La integración de la plataforma de LumiraDx mejorará el acceso de los pacientes a resultados diagnósticos oportunos y precisos en entornos sanitarios descentralizados a nivel mundial.
En enero de 2025, Danaher Corporation formó una alianza de inversión con Innovaccer Inc., una empresa de inteligencia artificial para el sector salud. Esta colaboración busca acelerar la adopción de diagnósticos de precisión y atención basada en el valor, proporcionando a los profesionales de la salud datos unificados de pacientes y análisis avanzados, mejorando así los resultados de los pacientes mediante intervenciones personalizadas y oportunas.
En octubre de 2024, bioMérieux hizo un llamado a la colaboración multisectorial para impulsar la agenda global sobre la resistencia a los antimicrobianos (RAM). La compañía enfatiza la urgente necesidad de aunar esfuerzos entre la atención médica, los gobiernos y la industria para abordar la RAM, promoviendo soluciones diagnósticas innovadoras y el uso responsable de antimicrobianos para combatir esta creciente amenaza para la salud mundial.
En marzo de 2024, Bio-Rad lanzó la solución de serotipificación de Salmonella mediante el ensayo XP-Design para realizar pruebas rápidas y precisas de seguridad alimentaria. Esta solución proporcionó un enfoque flexible para identificar serotipos de Salmonella tras el cribado inicial. Esta solución, lista para usar, contiene oligonucleótidos (cebadores y sondas) específicos del serotipo objetivo, lo que garantiza una alta especificidad y reduce el riesgo de reacción cruzada, ofreciendo resultados fiables.

SKU-74050

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Click on image to enlarge

Panel de análisis de datos interactivo
Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
Acceso de analista de investigación para personalización y consultas
Análisis de la competencia con panel interactivo
Últimas noticias, actualizaciones y análisis de tendencias
Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia

Solicitud de demostración

Tabla de contenido

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 YEARS CONSIDERED FOR THE STUDY

2.3 CURRENCY AND PRICING

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 MULTIVARIATE MODELLING

2.6 PRODUCT TYPE LIFELINE CURVE

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET END USER COVERAGE GRID

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 MICRO AND MACRO ECONOMIC FACTORS

4.4 PENETRATION AND GROWTH PROSPECT MAPPING

4.5 KEY PRICING STRATEGIES

4.6 COST ANALYSIS BREAKDOWN

4.7 OPPORTUNITY MAP ANALYSIS

4.8 VALUE CHAIN ANALYSIS

4.9 HEALTHCARE ECONOMY

4.1 TARIFFS

4.10.1 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR

4.10.2 GLOBAL VS. REGIONAL TARIFF STRUCTURES

4.10.3 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY

4.10.4 TARIFF REGULATIONS IN KEY MARKETS

4.10.4.1 MEDICARE/MEDICAID TARIFF POLICIES

4.10.4.2 CMS PRICING MODELS

4.10.4.3 OTHERS

4.10.5 TARIFFS ON MEDICAL DEVICES & EQUIPMENT

4.10.5.1 IMPORT/EXPORT DUTIES ON MEDICAL EQUIPMENT

4.10.5.2 IMPACT ON PRICING AND AVAILABILITY OF HIGH-END MEDICAL TECHNOLOGY

4.10.5.3 CASE STUDIES OF TARIFF CHANGES AFFECTING THE INDUSTRY

4.10.6 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES

4.10.7 TARIFF EXEMPTIONS AND INCENTIVES

4.10.8 DUTY-FREE IMPORTS FOR ESSENTIAL MEDICINES AND VACCINES

4.10.9 16.9 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN

4.10.10 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS

5 CUSTOMIZATION

5.1 LEADING DIGITAL HEALTH PLATFORMS IN EACH COUNTRY –

5.2 POCT DATA INTEGRATION USE CASES –

5.3 INFORMATICS PLATFORMS & TELEMEDICINE INTEGRATION:

6 REGULATORY

6.1 REGULATORY GSA

6.2 REGULATORY BENELUX

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES

7.1.2 RISING INCIDENCE OF SUBSTANCE ABUSE

7.1.3 INCREASED ADOPTION OF TELEMEDICINE

7.1.4 ADVANCEMENTS TECHNOLOGIES ENHANCING POC TESTING WITH BIOSENSORS AND MOBILE INTEGRATION

7.2 RESTRAINTS

7.2.1 DATA SECURITY AND PRIVACY CONCERNS

7.2.2 ACCURACY LIMITATIONS AND TECHNICAL BARRIERS

7.3 OPPORTUNITIES

7.3.1 RISING AWARENESS AND ADVOCACY FOR POINT-OF-CARE TESTING

7.3.2 STRATEGIC INITIATION AND DECISION TAKEN BY THE MARKET PLAYERS

7.3.3 EXPANDING PRODUCT RANGE FOR POINT-OF-CARE TESTING

7.4 CHALLENGES

7.4.1 LIMITED AWARENESS AND ACCEPTANCE OF POINT-OF-CARE (POC) TESTING

7.4.2 IMPACT OF HIGH MAINTENANCE COSTS THREATEN POINT-OF-CARE TESTING (POCT) SUSTAINABILITY IN LOW-RESOURCE SETTINGS

8 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 GLUCOSE MONITORING PRODUCTS

8.2.1 STRIPS

8.2.2 METERS

8.2.3 LANCETS AND LANCING DEVICES

8.3 INFECTIOUS DISEASE TESTING PRODUCTS

8.3.1 COVID-19

8.3.2 HIV TESTING PRODUCTS

8.3.2.1 TESTING REAGENTS

8.3.2.2 TESTING EQUIPMENT

8.3.3 RESPIRATORY INFECTION TESTING PRODUCTS

8.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING

8.3.4.1 NAAT-BASED SYSTEMS

8.3.4.2 NON–NAAT-BASED SYSTEMS

8.3.5 HEPATITIS C TESTING PRODUCTS

8.3.5.1 HCV ANTIBODY TESTS

8.3.5.2 HCV VIRAL LOAD TESTS

8.3.6 INFLUENZA TESTING PRODUCTS

8.3.6.1 TRADITIONAL DIAGNOSTIC TEST

8.3.6.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)

8.3.6.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT)

8.3.6.1.3 VIRAL CULTURE

8.3.6.1.4 SEROLOGICAL ASSAY

8.3.6.2 MOLECULAR DIAGNOSTIC ASSAY

8.3.6.2.1 RT-PCR

8.3.6.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)

8.3.6.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)

8.3.6.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)

8.3.7 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING

8.3.8 TROPICAL DISEASE TESTING PRODUCTS

8.3.9 OTHER INFECTIOUS DISEASE TESTING PRODUCTS

8.4 CARDIOMETABOLIC MONITORING PRODUCTS

8.4.1 CARDIAC MARKER TESTING PRODUCTS

8.4.1.1 HSTNL

8.4.1.2 BNP

8.4.1.3 D-DIMER

8.4.1.4 CK-MB

8.4.1.5 MYOGLOBIN

8.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS

8.4.3 BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES

8.4.3.1 CARTRIDGES

8.4.3.2 REAGENTS

8.4.4 BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS

8.4.4.1 PORTABLE

8.4.4.1.1 COMBINED ANALYZERS

8.4.4.1.2 BLOOD GAS ANALYZERS

8.4.4.1.3 ELECTROLYTE ANALYZERS

8.4.4.2 BENCHTOP

8.4.4.2.1 COMBINED ANALYZERS

8.4.4.2.2 BLOOD GAS ANALYZERS

8.4.4.2.3 ELECTROLYTE ANALYZERS

8.4.5 HBA1C TESTING PRODUCTS

8.4.5.1 HBA1C TESTING INSTRUMENTS

8.4.5.2 HBA1C TESTING CONSUMABLES

8.4.6 POC ANALYZER

8.4.7 ECG DEVICE

8.4.7.1 RESTING ECG DEVICES

8.4.7.2 STRESS ECG DEVICES

8.4.7.3 HOLTER MONITORS

8.5 PREGNANCY AND FERTILITY TESTING PRODUCTS

8.5.1 PREGNANCY TESTING PRODUCTS

8.5.1.1 STRIPS/ DIP STICKS AND CARDS

8.5.1.2 MID STREAM DEVICES

8.5.1.3 CASSETTES

8.5.1.4 DIGITAL DEVICES

8.5.1.5 LINE-INDICATOR DEVICES

8.5.2 FERTILITY TESTING PRODUCTS

8.5.2.1 LUTEINIZING HORMONE (LH) URINE TEST

8.5.2.2 FSH TEST

8.5.2.3 OTHERS

8.6 HAEMATOLOGY TESTING PRODUCTS

8.7 COAGULATION MONITORING PRODUCTS

8.7.1 ANTICOAGULATION MONITORING DEVICES

8.7.1.1 PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES

8.7.1.2 ACTIVATED CLOTTING TIME (ACT)

8.7.1.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT)

8.7.2 PLATELET FUNCTION MONITORING DEVICES

8.7.3 VISCOELASTIC COAGULATION MONITORING DEVICES

8.7.3.1 ROTATIONAL THROMBOELASTOMETRY (ROTEM)

8.7.3.2 THROMBOELASTOGRAPHY (TEG)

8.8 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS

8.8.1 DOA ANALYSERS

8.8.1.1 IMMUNOASSAYS

8.8.1.2 CHROMATOGRAPHIC DEVICES

8.8.1.3 BREATH ANALYSERS

8.8.2 RAPID TESTING DEVICES

8.8.2.1 URINE TESTING DEVICES

8.8.2.2 ORAL FLUID TESTING DEVICES

8.8.2.3 OTHERS

8.9 URINALYSIS TESTING PRODUCTS

8.9.1 POC URINE STRIP SELF-TESTING

8.9.2 POC URINE TEST STRIP PROFESSIONAL TESTING

8.1 CHOLESTEROL TESTING PRODUCTS

8.10.1 TESTING KITS

8.10.2 INSTRUMENTS

8.10.2.1 TABLE-TOP ANALYZERS

8.10.2.2 HAND-HELD ANALYZERS

8.11 TUMOR/CANCER MARKER TESTING PRODUCTS

8.12 FECAL OCCULT TESTING PRODUCTS

8.12.1 GUAIAC FOB STOOL TEST

8.12.2 LATERAL FLOW IMMUNO-FOB TEST

8.12.3 IMMUNO-FOB AGGLUTINATION TEST

8.12.4 IMMUNO-FOB ELISA TEST

8.13 OTHERS

9 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE

9.1 OVERVIEW

9.2 OTC TESTING

9.3 PRESCRIPTION-BASED TESTING

10 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM

10.1 OVERVIEW

10.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS

10.3 IMMUNOASSAYS

10.4 DIPSTICKS

10.5 MOLECULAR DIAGNOSTICS

10.6 CLINICAL CHEMISTRY ASSAYS

10.7 MICROFLUIDICS

10.8 HEMATOLOGY

10.9 OTHERS

11 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 BLOOD GLUCOSE

11.3 INFECTIOUS DISEASES

11.3.1 COVID-19 TESTING

11.3.2 HIV TESTING

11.3.3 HEPATITIS C TESTING

11.3.4 INFLUENZA TESTING

11.3.5 TUBERCULOSIS TESTING

11.3.6 OTHERS

11.4 VITAL SIGN MONITORING

11.5 CARDIAC MONITORING

11.6 COAGULATION

11.7 HAEMATOLOGY

11.8 NON- INVASIVE SPO2 MONITORING

11.9 BLOOD TRANSFUSION

11.1 NON- INVASIVE PCO2 MONITORING

11.11 WHOLE BLOOD ANALYSIS

11.12 OTHERS

12 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.2.1 PRIVATE

12.2.1.1 TIER 1

12.2.1.2 TIER 2

12.2.1.3 TIER 3

12.2.2 PUBLIC

12.3 HOME CARE

12.4 CLINICS

12.5 LABORATORIES

12.6 DIAGNOSTIC CENTERS

12.7 PATHOLOGY LABS

12.8 AMBULATORY SURGERY CENTERS

12.9 ELDERLY CARE CENTERS

12.1 OTHERS

13 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER

13.3 RETAIL SALES

13.4 ONLINE SALES

13.5 OTHERS

14 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE

14.1 OVERVIEW

14.2 GLUCOSE MONITORING PRODUCTS

14.2.1 STRIPS

14.2.2 METERS

14.2.3 LANCETS AND LANCING DEVICES

14.3 INFECTIOUS DISEASE TESTING PRODUCTS

14.3.1 COVID-19

14.3.2 HIV TESTING PRODUCTS

14.3.2.1 TESTING REAGENTS

14.3.2.2 TESTING EQUIPMENT

14.3.3 RESPIRATORY INFECTION TESTING PRODUCTS

14.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING

14.3.5 NAAT-BASED SYSTEMS

14.3.6 NON–NAAT-BASED SYSTEMS

14.3.7 HEPATITIS C TESTING PRODUCTS

14.3.7.1 HCV ANTIBODY TESTS

14.3.7.2 HCV VIRAL LOAD TESTS

14.3.8 INFLUENZA TESTING PRODUCTS

14.3.8.1 TRADITIONAL DIAGNOSTIC TEST

14.3.8.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)

14.3.8.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT)

14.3.8.1.3 VIRAL CULTURE

14.3.8.1.4 SEROLOGICAL ASSAY

14.3.8.2 MOLECULAR DIAGNOSTIC ASSAY

14.3.8.2.1 RT-PCR

14.3.8.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)

14.3.8.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)

14.3.8.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)

14.3.9 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING

14.3.10 TROPICAL DISEASE TESTING PRODUCTS

14.3.11 OTHER INFECTIOUS DISEASE TESTING PRODUCTS

14.4 CARDIOMETABOLIC MONITORING PRODUCTS

14.4.1 CARDIAC MARKER TESTING PRODUCTS

14.4.1.1 HSTNL

14.4.1.2 BNP

14.4.1.3 D-DIMER

14.4.1.4 CK-MB

14.4.1.5 MYOGLOBIN

14.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS

14.4.3 BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES

14.4.3.1 CARTRIDGES

14.4.3.2 REAGENTS

14.4.4 BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS

14.4.5 PORTABLE

14.4.5.1 COMBINED ANALYZERS

14.4.5.2 BLOOD GAS ANALYZERS

14.4.5.3 ELECTROLYTE ANALYZERS

14.4.6 BENCHTOP

14.4.6.1 COMBINED ANALYZERS

14.4.6.2 BLOOD GAS ANALYZERS

14.4.6.3 ELECTROLYTE ANALYZERS

14.4.7 HBA1C TESTING PRODUCTS

14.4.7.1 HBA1C TESTING INSTRUMENTS

14.4.7.2 HBA1C TESTING CONSUMABLES

14.4.8 POC ANALYZER

14.4.9 ECG DEVICE

14.4.9.1 RESTING ECG DEVICES

14.4.9.2 STRESS ECG DEVICES

14.4.9.3 HOLTER MONITORS

14.5 PREGNANCY AND FERTILITY TESTING PRODUCTS

14.5.1 PREGNANCY TESTING PRODUCTS

14.5.1.1 STRIPS/ DIP STICKS AND CARDS

14.5.1.2 MID STREAM DEVICES

14.5.1.3 CASSETTES

14.5.1.4 DIGITAL DEVICES

14.5.1.5 LINE-INDICATOR DEVICES

14.5.2 FERTILITY TESTING PRODUCTS

14.5.2.1 LUTEINIZING HORMONE (LH) URINE TEST

14.5.2.2 FSH TEST

14.5.2.3 OTHERS

14.6 HAEMATOLOGY TESTING PRODUCTS

14.7 COAGULATION MONITORING PRODUCTS

14.8 ANTICOAGULATION MONITORING DEVICES

14.8.1 PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES

14.8.2 ACTIVATED CLOTTING TIME (ACT)

14.8.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT)

14.8.4 PLATELET FUNCTION MONITORING DEVICES

14.8.5 VISCOELASTIC COAGULATION MONITORING DEVICES

14.8.5.1 ROTATIONAL THROMBOELASTOMETRY (ROTEM)

14.8.5.2 THROMBOELASTOGRAPHY (TEG)

14.9 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS

14.9.1 DOA ANALYSERS

14.9.1.1 IMMUNOASSAYS

14.9.1.2 CHROMATOGRAPHIC DEVICES

14.9.1.3 BREATH ANALYSERS

14.9.2 RAPID TESTING DEVICES

14.9.2.1 URINE TESTING DEVICES

14.9.2.2 ORAL FLUID TESTING DEVICES

14.9.3 OTHERS

14.1 URINALYSIS TESTING PRODUCTS

14.10.1 POC URINE STRIP SELF-TESTING

14.10.2 POC URINE TEST STRIP PROFESSIONAL TESTING

14.11 CHOLESTEROL TESTING PRODUCTS

14.11.1 TESTING KITS

14.11.2 INSTRUMENTS

14.11.2.1 TABLE-TOP ANALYZERS

14.11.2.2 HAND-HELD ANALYZERS

14.12 TUMOR/CANCER MARKER TESTING PRODUCTS

14.13 FECAL OCCULT TESTING PRODUCTS

14.13.1 GUAIAC FOB STOOL TEST

14.13.2 LATERAL FLOW IMMUNO-FOB TEST

14.13.3 IMMUNO-FOB AGGLUTINATION TEST

14.13.4 IMMUNO-FOB ELISA TEST

14.14 OTHERS

15 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM

15.1 OVERVIEW

15.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS

15.3 IMMUNOASSAYS

15.4 DIPSTICKS

15.5 MOLECULAR DIAGNOSTICS

15.6 CLINICAL CHEMISTRY ASSAYS

15.7 MICROFLUIDICS

15.8 HEMATOLOGY

15.9 OTHERS

16 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE

16.1 OVERVIEW

16.2 OTC TESTING

16.3 PRESCRIPTION-BASED TESTING

17 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION

17.1 OVERVIEW

17.2 BLOOD GLUCOSE

17.3 INFECTIOUS DISEASES

17.3.1.1 COVID-19 TESTING

17.3.1.2 HIV TESTING

17.3.1.3 HEPATITIS C TESTING

17.3.1.4 INFLUENZA TESTING

17.3.1.5 TUBERCULOSIS TESTING

17.3.1.6 OTHERS

17.4 VITAL SIGN MONITORING

17.5 CARDIAC MONITORING

17.6 COAGULATION

17.7 HAEMATOLOGY

17.8 NON- INVASIVE SPO2 MONITORING

17.9 BLOOD TRANSFUSION

17.1 NON- INVASIVE PCO2 MONITORING

17.11 WHOLE BLOOD ANALYSIS

17.12 OTHERS

18 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY END USER

18.1 OVERVIEW

18.2 HOSPITALS

18.2.1 PRIVATE

18.2.1.1 TIER 1

18.2.1.2 TIER 2

18.2.1.3 TIER 3

18.2.2 PUBLIC

18.3 HOME CARE

18.4 CLINICS

18.5 LABORATORIES

18.6 DIAGNOSTIC CENTERS

18.7 PATHOLOGY LABS

18.8 AMBULATORY SURGERY CENTERS

18.9 ELDERLY CARE CENTERS

18.1 OTHERS

19 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL

19.1 OVERVIEW

19.2 DIRECT TENDER

19.3 RETAIL SALES

19.4 ONLINE SALES

19.5 OTHERS

20 GSA & BENELUX

20.1 GERMANY

20.2 NETHERLANDS

20.3 SWITZERLAND

20.4 BELGIUM

20.5 AUSTRIA

20.6 LUXEMBOURG

21 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY LANDSCAPE

21.1 COMPANY SHARE ANALYSIS: GSA AND BENELUX

22 SWOT ANALYSIS

23 COMPANY PROFILE

23.1 F. HOFFMANN-LA ROCHE LTD

23.1.1 COMPANY SNAPSHOT

23.1.2 REVENUE ANALYSIS

23.1.3 PRODUCT PORTFOLIO

23.1.4 RECENT DEVELOPMENT

23.2 DANAHER CORPORATION

23.2.1 COMPANY SNAPSHOT

23.2.2 REVENUE ANALYSIS

23.2.3 PRODUCT PORTFOLIO

23.2.4 RECENT DEVELOPMENT

23.3 SIEMENS HEALTHINEERS AG

23.3.1 COMPANY SNAPSHOT

23.3.2 REVENUE ANALYSIS

23.3.3 PRODUCT PORTFOLIO

23.3.4 RECENT DEVELOPMENT

23.4 BIO- RAD LABORATORIES, INC.

23.4.1 COMPANY SNAPSHOT

23.4.2 REVENUE ANALYSIS

23.4.3 PRODUCT PORTFOLIO

23.4.4 RECENT DEVELOPMENT

23.5 BIOMERIEUX

23.5.1 COMPANY SNAPSHOT

23.5.2 REVENUE ANALYSIS

23.5.3 PRODUCT PORTFOLIO

23.5.4 RECENT DEVELOPMENT

23.6 ACCUBIOTECH CO., LTD.

23.6.1 COMPANY SNAPSHOT

23.6.2 PRODUCT PORTFOLIO

23.6.3 RECENT DEVELOPMENT

23.7 ABBOTT

23.7.1 COMPANY SNAPSHOT

23.7.2 REVENUE ANALYSIS

23.7.3 PRODUCT PORTFOLIO

23.7.4 RECENT DEVELOPMENT/NEWS

23.8 BINX HEALTH

23.8.1 COMPANY SNAPSHOT

23.8.2 SOLUTION PORTFOLIO

23.8.3 RECENT DEVELOPMENT

23.9 BD

23.9.1 COMPANY SNAPSHOT

23.9.2 REVENUE ANALYSIS

23.9.3 PRODUCT PORTFOLIO

23.9.4 RECENT DEVELOPMENT/NEWS

23.1 EKF DIAGNOSTICS HOLDINGS PLC

23.10.1 COMPANY SNAPSHOT

23.10.2 REVENUE ANALYSIS

23.10.3 PRODUCT PORTFOLIO

23.10.4 RECENT DEVELOPMENT

23.11 HOLOGIC, INC

23.11.1 COMPANY SNAPSHOT

23.11.2 REVENUE ANALYSIS

23.11.3 PRODUCT PORTFOLIO

23.11.4 RECENT DEVELOPMENT

23.12 MERIDIAN BIOSCIENCE, INC.

23.12.1 COMPANY SNAPSHOT

23.12.2 PRODUCT PORTFOLIO

23.12.3 RECENT DEVELOPMENT/NEWS

23.13 QIAGEN

23.13.1 COMPANY SNAPSHOT

23.13.2 REVENUE ANALYSIS

23.13.3 PRODUCT PORTFOLIO

23.13.4 RECENT DEVELOPMENT

23.14 QUIDELORTHO CORPORATION

23.14.1 COMPANY SNAPSHOT

23.14.2 REVENUE ANALYSIS

23.14.3 PRODUCT PORTFOLIO

23.14.4 RECENT DEVELOPMENT

23.15 SEKISUI DIAGNOSTICS

23.15.1 COMPANY SNAPSHOT

23.15.2 PRODUCT PORTFOLIO

23.15.3 RECENT DEVELOPMENT

23.16 SYSMEX CORPORATION

23.16.1 COMPANY SNAPSHOT

23.16.2 REVENUE ANALYSIS

23.16.3 PRODUCT PORTFOLIO

23.16.4 RECENT DEVELOPMENT

23.17 SIENCO, INC.

23.17.1 COMPANY SNAPSHOT

23.17.2 PRODUCT PORTFOLIO

23.17.3 RECENT DEVELOPMENT

23.18 TRINITY BIOTECH

23.18.1 COMPANY SNAPSHOT

23.18.2 REVENUE ANALYSIS

23.18.3 PRODUCT PORTFOLIO

23.18.4 RECENT DEVELOPMENT

23.19 THERMO FISHER SCIENTIFIC INC.

23.19.1 COMPANY SNAPSHOT

23.19.2 REVENUE ANALYSIS

23.19.3 PRODUCT PORTFOLIO

23.19.4 RECENT DEVELOPMENT

23.2 WERFEN

23.20.1 COMPANY SNAPSHOT

23.20.2 PRODUCT PORTFOLIO

23.20.3 RECENT DEVELOPMENT

24 QUESTIONNAIRE

Lista de Tablas

TABLE 1 HOME-USE POCT DEVICES WITH TELEMEDICINE INTEGRATION

TABLE 2 COMPANIES AND PRODUCTS WITH TELEMEDICINE INTEGRATION

TABLE 3 A TECHNOLOGY ROADMAP OUTLINING THE FUTURE OF CONNECTED POCT DEVICES

TABLE 4 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 5 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 6 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 7 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 8 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 9 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 10 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 11 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 12 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 13 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 14 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 15 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 16 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 17 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 18 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 19 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 20 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 21 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 22 GSA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 23 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 24 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 25 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 26 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 27 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 28 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 29 GSA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 30 GSA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 31 GSA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 32 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 33 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 34 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 35 GSA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 36 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 37 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 38 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 39 GSA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 40 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 41 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 42 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 43 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 44 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 45 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 46 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 47 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 48 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 49 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 50 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 51 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 52 GSA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 53 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 54 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 55 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 56 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 58 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 59 GSA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 60 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 61 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 62 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 63 GSA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 64 GSA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 65 GSA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 66 GSA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNIT)

TABLE 67 GSA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 68 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 69 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 70 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 71 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 72 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 73 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 74 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 76 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 77 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 78 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 79 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 80 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 81 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 82 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 83 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 84 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 85 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 86 GSA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 87 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 88 GSA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 GSA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 90 GSA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 91 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 92 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 93 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 94 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 95 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 96 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 97 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 98 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 99 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 100 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 101 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 102 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 103 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 104 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 105 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 106 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 107 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 108 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 109 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 110 BENELUX INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 112 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 113 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 114 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 115 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 116 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 117 BENELUX CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 118 BENELUX POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 119 BENELUX POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 120 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 121 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 122 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 123 BENELUX BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 124 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 125 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 126 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 127 BENELUX BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 128 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 129 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 130 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 131 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 132 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 133 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 134 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 135 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 136 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 137 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 138 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 139 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 140 BENELUX PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 142 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 143 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 144 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 145 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 146 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 147 BENELUX COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 148 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 149 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 150 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 151 BENELUX VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 152 BENELUX DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 BENELUX DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 154 BENELUX DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNIT)

TABLE 155 BENELUX DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 156 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 157 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 158 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 159 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 160 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 161 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 162 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 163 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 164 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 165 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 166 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 167 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 168 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 169 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 170 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 171 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 172 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 173 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 174 BENELUX INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 175 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 176 BENELUX HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 177 BENELUX PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 178 BENELUX PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 179 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 180 GSA & BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 181 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 182 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 183 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 184 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 185 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 186 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 187 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 188 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 189 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 190 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 191 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 192 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 193 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 194 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 195 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 196 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 197 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 198 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 199 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 200 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 201 GERMANY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 202 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 203 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 204 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 205 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 206 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 207 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 208 GERMANY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 209 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 210 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 211 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 212 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 213 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 214 GERMANY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 215 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 216 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 217 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 218 GERMANY BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 219 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 220 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 221 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 222 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 223 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 224 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 225 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 226 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 227 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 228 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 229 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 230 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 231 GERMANY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 232 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 233 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 234 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 235 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 236 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 237 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 238 GERMANY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 239 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 240 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 241 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 242 GERMANY VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 243 GERMANY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 244 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 245 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 246 GERMANY DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 247 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 248 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 249 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 250 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 251 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 252 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 253 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 254 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 255 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 256 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 257 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 258 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 259 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 260 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 261 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 262 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 263 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 264 GERMANY INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 265 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 266 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 267 GERMANY HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 268 GERMANY PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 269 GERMANY PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 270 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 271 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 272 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 273 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 274 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 275 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 276 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 277 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 278 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 279 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 280 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 281 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 282 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 283 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 284 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 285 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 286 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 287 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 288 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 289 NETHERLANDS INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 290 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 291 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 292 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 293 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 294 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 295 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 296 NETHERLANDS CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 297 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 298 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 299 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 300 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 301 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 302 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 303 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 304 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 305 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 306 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 307 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 308 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 309 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 310 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 311 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 312 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 313 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 314 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 315 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 316 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 317 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 318 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 319 NETHERLANDS PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 320 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 321 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 322 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 323 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 324 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 325 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 326 NETHERLANDS COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 327 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 328 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 329 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 330 NETHERLANDS VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 331 NETHERLANDS DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 332 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 333 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 334 NETHERLANDS DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 335 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 336 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 337 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 338 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 339 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 340 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 341 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 342 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 343 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 344 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 345 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 346 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 347 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 348 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 349 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 350 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 351 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 352 NETHERLANDS INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 353 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 354 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 355 NETHERLANDS HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 356 NETHERLANDS PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 357 NETHERLANDS PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 358 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 359 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 360 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 361 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 362 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 363 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 364 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 365 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 366 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 367 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 368 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 369 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 370 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 371 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 372 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 373 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 374 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 375 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 376 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 377 SWITZERLAND INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 378 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 379 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 380 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 381 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 382 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 383 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 384 SWITZERLAND CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 385 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 386 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 387 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 388 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 389 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 390 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 391 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 392 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 393 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 394 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 395 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 396 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 397 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 398 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 399 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 400 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 401 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 402 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 403 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 404 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 405 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 406 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 407 SWITZERLAND PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 408 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 409 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 410 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 411 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 412 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 413 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 414 SWITZERLAND COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 415 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 416 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 417 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 418 SWITZERLAND VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 419 SWITZERLAND DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 420 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 421 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 422 SWITZERLAND DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 423 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 424 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 425 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 426 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 427 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 428 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 429 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 430 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 431 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 432 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 433 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 434 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 435 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 436 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 437 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 438 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 439 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 440 SWITZERLAND INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 441 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 442 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 443 SWITZERLAND HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 444 SWITZERLAND PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 445 SWITZERLAND PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 446 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 447 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 448 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 449 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 450 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 451 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 452 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 453 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 454 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 455 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 456 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 457 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 458 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 459 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 460 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 461 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 462 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 463 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 464 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 465 BELGIUM INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 466 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 467 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 468 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 469 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 470 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 471 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 472 BELGIUM CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 473 BELGIUM POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 474 BELGIUM POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 475 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 476 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 477 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 478 BELGIUM BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 479 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 480 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 481 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 482 BELGIUM BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 483 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 484 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 485 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 486 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 487 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 488 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 489 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 490 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 491 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 492 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 493 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 494 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 495 BELGIUM PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 496 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 497 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 498 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 499 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 500 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 501 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 502 BELGIUM COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 503 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 504 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 505 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 506 BELGIUM VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 507 BELGIUM DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 508 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 509 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 510 BELGIUM DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 511 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 512 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 513 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 514 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 515 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 516 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 517 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 518 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 519 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 520 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 521 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 522 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 523 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 524 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 525 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 526 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 527 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 528 BELGIUM INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 529 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 530 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 531 BELGIUM HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 532 BELGIUM PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 533 BELGIUM PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 534 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 535 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 536 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 537 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 538 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 539 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 540 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 541 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 542 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 543 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 544 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 545 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 546 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 547 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 548 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 549 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 550 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 551 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 552 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 553 AUSTRIA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 554 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 555 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 556 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 557 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 558 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 559 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 560 AUSTRIA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 561 AUSTRIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 562 AUSTRIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 563 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 564 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 565 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 566 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 567 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 568 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 569 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 570 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 571 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 572 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 573 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 574 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 575 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 576 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 577 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 578 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 579 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 580 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 581 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 582 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 583 AUSTRIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 584 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 585 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 586 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 587 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 588 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 589 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 590 AUSTRIA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 591 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 592 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 593 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 594 AUSTRIA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 595 AUSTRIA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 596 AUSTRIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 597 AUSTRIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 598 AUSTRIA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 599 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 600 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 601 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 602 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 603 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 604 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 605 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 606 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 607 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 608 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 609 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 610 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 611 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 612 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 613 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 614 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 615 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 616 AUSTRIA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 617 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 618 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 619 AUSTRIA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 620 AUSTRIA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 621 AUSTRIA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 622 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 623 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 624 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 625 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 626 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 627 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 628 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 629 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 630 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 631 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 632 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 633 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 634 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 635 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 636 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 637 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 638 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 639 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 640 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 641 LUXEMBOURG INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 642 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 643 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 644 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 645 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 646 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 647 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 648 LUXEMBOURG CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 649 LUXEMBOURG POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 650 LUXEMBOURG POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 651 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 652 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 653 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 654 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 655 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 656 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 657 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 658 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 659 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 660 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 661 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 662 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 663 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 664 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 665 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 666 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 667 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 668 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 669 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 670 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 671 LUXEMBOURG PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 672 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 673 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 674 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 675 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 676 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 677 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 678 LUXEMBOURG COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 679 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 680 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 681 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 682 LUXEMBOURG VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 683 LUXEMBOURG DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 684 LUXEMBOURG DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 685 LUXEMBOURG DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 686 LUXEMBOURG DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 687 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 688 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 689 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 690 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 691 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 692 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 693 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 694 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 695 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 696 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 697 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 698 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 699 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 700 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 701 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 702 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 703 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 704 LUXEMBOURG INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 705 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 706 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 707 LUXEMBOURG HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 708 LUXEMBOURG PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 709 LUXEMBOURG PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 710 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

Lista de figuras

FIGURE 1 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION

FIGURE 2 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DATA TRIANGULATION

FIGURE 3 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DROC ANALYSIS

FIGURE 4 GSA POINT-OF-CARE-TESTING (POCT) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 6 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 7 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION

FIGURE 11 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE (2024)

FIGURE 12 BEMELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE (2024)

FIGURE 13 GSA POINT-OF-CARE-TESTING (POCT) MARKET: EXECUTIVE SUMMARY

FIGURE 14 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: EXECUTIVE SUMMARY

FIGURE 15 STRATEGIC DECISIONS

FIGURE 16 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE GSA POINT-OF-CARE-TESTING (POCT) MARKET, IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 17 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 18 GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GSA POINT-OF-CARE-TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2025 & 2032

FIGURE 19 GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BENELUX POINT-OF-CARE-TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2025 & 2032

FIGURE 20 DROC ANALYSIS

FIGURE 21 NUMBER OF PEOPLE USING VARIOUS SUBSTANCES OR EXPERIENCING PROBLEMATIC USE PREVALENCE (PERCENTAGE)

FIGURE 22 NUMBER OF PEOPLE USING VARIOUS SUBSTANCES OR EXPERIENCING PROBLEMATIC USE (IN MILLION)

FIGURE 23 SUBSTANCE USE BEHAVIOURS AMONG 15-YEAR-OLDS IN 2022 (SELF-REPORTED PREVALENCE)

FIGURE 24 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2024

FIGURE 25 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 26 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2025-2032)

FIGURE 27 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 28 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2024

FIGURE 29 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025 TO 2032 (USD THOUSAND)

FIGURE 30 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2025- 2032)

FIGURE 31 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE

FIGURE 32 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2024

FIGURE 33 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025 TO 2032 (USD THOUSAND)

FIGURE 34 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2025- 2032)

FIGURE 35 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 36 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2024

FIGURE 37 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)

FIGURE 38 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2025- 2032)..

FIGURE 39 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 40 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2024

FIGURE 41 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)

FIGURE 42 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2025- 2032)

FIGURE 43 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE

FIGURE 44 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 45 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)

FIGURE 46 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)

FIGURE 47 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 48 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2024

FIGURE 49 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 50 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2025-2032)

FIGURE 51 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 52 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2024

FIGURE 53 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025 TO 2032 (USD THOUSAND)

FIGURE 54 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2025- 2032)

FIGURE 55 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 56 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2024

FIGURE 57 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025 TO 2032 (USD THOUSAND)

FIGURE 58 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2025- 2032)

FIGURE 59 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE

FIGURE 60 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2024

FIGURE 61 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)

FIGURE 62 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2025- 2032)

FIGURE 63 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 64 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2024

FIGURE 65 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)

FIGURE 66 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2025- 2032)

FIGURE 67 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE

FIGURE 68 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 69 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)

FIGURE 70 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)

FIGURE 71 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 72 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT (2024)

FIGURE 73 GSA POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT (2024)

FIGURE 74 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY SHARE 2024 (%)

Ver información detallada

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Preguntas frecuentes

¿Cuáles son los principales segmentos cubiertos en el informe Informe de análisis del tamaño, la participación y las tendencias del mercado?

El mercado se segmenta según Mercado de pruebas en el punto de atención (POCT) de GSA y Benelux, por tipo de producto (productos para el control de glucosa, productos para el análisis de enfermedades infecciosas, productos para el control cardiometabólico, productos para el análisis de embarazo y fertilidad, productos para el análisis de hematología, productos para el control de la coagulación, productos para el análisis de drogas de abuso (DOA), productos para el análisis de orina, productos para el análisis de colesterol, productos para el análisis de marcadores tumorales/cancerosos, productos para el análisis de heces ocultas y otros), por plataforma (ensayos de flujo lateral/pruebas de inmunocromatografía, inmunoensayos, tiras reactivas, diagnóstico molecular, ensayos de química clínica, microfluídica, hematología, otros), por aplicación (glucosa en sangre, enfermedades infecciosas, monitorización de signos vitales, monitorización cardíaca, coagulación, hematología, monitorización no invasiva de SpO2, transfusión sanguínea, monitorización no invasiva de PCO2, sangre completa Análisis, otros), por modo de prescripción (pruebas con receta y pruebas sin receta, por usuario final (hospitales, atención domiciliaria, clínicas, laboratorios, centros de diagnóstico, laboratorios de patología, centros de cirugía ambulatoria, centros de atención para personas mayores, otros), por canal de distribución (licitación directa, ventas minoristas, ventas en línea y otros) - Tendencias y pronóstico de la industria hasta 2032 .

¿Cuál es el tamaño actual del mercado de Informe de análisis del tamaño, la participación y las tendencias del mercado?

El tamaño del Informe de análisis del tamaño, la participación y las tendencias del mercado se valoró en 3.63 USD Billion USD en 2024.

¿Cuál es la tasa de crecimiento esperada del Informe de análisis del tamaño, la participación y las tendencias del mercado?

Se prevé que el Informe de análisis del tamaño, la participación y las tendencias del mercado crezca a una CAGR de 12.1% durante el período de pronóstico de 2025 a 2032.

¿Quiénes son los principales actores en el Informe de análisis del tamaño, la participación y las tendencias del mercado?

Los principales actores del mercado incluyen F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthineers AG, Bio-Rad Laboratories Inc., BIOMÉRIEUX.

Informe de análisis del tamaño, la participación y las tendencias del mercado de pruebas en el punto de atención (POCT) de GSA y Benelux: descripción general del sector y pronóstico hasta 2032

Supera los desafíos arancelarios con una consultoría ágil de la cadena de suministro

Gsa And Benelux Point Care Testing Poct Market

Tasa de crecimiento anual compuesta (CAGR) : 12.10 %

Tamaño del mercado de pruebas en el punto de atención (POCT)

Análisis del mercado de pruebas en el punto de atención (POCT)

Alcance del mercado de las pruebas en el punto de atención (POCT)

Alemania posee la mayor participación en el mercado de pruebas en el punto de atención (POCT)

Se proyecta que Países Bajos registre la tasa de crecimiento anual compuesta (TCAC) más alta en el mercado de pruebas en el punto de atención (POCT)

Cuota de mercado de las pruebas en el punto de atención (POCT)

Últimos avances en el mercado de pruebas en el punto de atención (POCT) de GSA y Benelux

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Tabla de contenido

Lista de Tablas

Lista de figuras

Metodología de investigación

Personalización disponible

Preguntas frecuentes

Informes

Perspectivas del mercado

Apoyo

Soluciones

Informe de análisis del tamaño, la participación y las tendencias del mercado de pruebas en el punto de atención (POCT) de GSA y Benelux: descripción general del sector y pronóstico hasta 2032

Supera los desafíos arancelarios con una consultoría ágil de la cadena de suministro

Gsa And Benelux Point Care Testing Poct Market

Tasa de crecimiento anual compuesta (CAGR) : 12.10 %

Tamaño del mercado de pruebas en el punto de atención (POCT)

Análisis del mercado de pruebas en el punto de atención (POCT)

Alcance del mercado de las pruebas en el punto de atención (POCT)

Alemania posee la mayor participación en el mercado de pruebas en el punto de atención (POCT)

Se proyecta que Países Bajos registre la tasa de crecimiento anual compuesta (TCAC) más alta en el mercado de pruebas en el punto de atención (POCT)

Cuota de mercado de las pruebas en el punto de atención (POCT)

Últimos avances en el mercado de pruebas en el punto de atención (POCT) de GSA y Benelux

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Tabla de contenido

Lista de Tablas

Lista de figuras

Metodología de investigación

Personalización disponible

Preguntas frecuentes

Explorar páginas relacionadas